| 09:00-09:30 |
Registration |
|
| 09:30-10:10 |
Opening Remarks |
|
| 10:10-10:30 |
Presentation Session 1 : Building a novel pandemic preparedness program |
Speaker : Dr. Daniel Douek (NIAID,USA) |
Chair : 김우주 교수 (고려대학교 의과대학) |
| 10:30-10:40 |
Q&A |
| 10:40-11:00 |
Presentation Session 2 : Development of therapeutic human monoclonal antibodies against SFTSV infection |
Speaker : Dr. Han-saem Lee (NIID,Korea) |
| 11:00-11:10 |
Q&A |
| 11:10-11:30 |
Presentation Session 3 : Bacteriophages and Endolysins Combating Multidrug Resistant (MDR) Pathogens |
Speaker : Dr. Hee-joon Myung (LyseNTech,Korea) |
Chair : 오명돈 교수 (서울대학교 의과대학) |
| 11:30-11:40 |
Q&A |
| 11:40-12:00 |
Presentation Session 4 : NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins |
Speaker : Dr. Dennis Dixon (NIAID,USA) |
| 12:00-12:10 |
Q&A |
| 12:10-13:30 |
Lunch |
|
| 13:30-13:50 |
Presentation Session 5 : Flagellin as a potent immune modulator for the elderly |
Speaker : Dr. Kyung-a Cho (Pharmaceutical Company,Korea) |
Chair : 성백린 교수 (연세대학교 의과대학) |
| 13:50-14:00 |
Q&A |
| 14:00-14:20 |
Presentation Session 6 : accine adjuvants research |
Speaker : Dr. Kentner Leroy Singleton (NIAID,USA) |
| 14:20-14:30 |
Q&A |
| 14:30-14:50 |
Presentation Session 7 : The future of pandemic preparedness: Building collaborations and EV-D68 as a test case for NIAID/VRC's PREMISE program |
Speaker : Dr. Alicen Spaulding (NIAID,USA) |
| 14:50-15:00 |
Q&A |
| 15:00-15:10 |
Break |
|
| 15:10-15:40 |
Panel Discussion |
|
| 15:40-17:10 |
Meeting to Discuss Potential Collaborations |
|
| 17:10-18:10 |
Break |
|
| 18:10- |
Dinner |
|
| Meeting to Discuss Potential Collaborations (Expected participants) |
